Dialister

Depletion as a Biomarker#

Dialister abundance is one of the most consistent protective markers in depression research. Multiple independent cohorts demonstrate. Significantly lower relative abundance (often <0.5% in depressed individuals vs. >2% in healthy controls).^{[1]Zhou 2024 — Association of Maternal Postpartum Depression Symptoms with Infant Neurodevelopment and Gut MicrobiotaLepeng Zhou, Linghong Tang, Chuhui Zhou et al. · 2024Open reference 1 ↓[2]Romano 2023 — Gut Microbiome in Children with Mood, Anxiety, and NDDs: Umbrella ReviewKaitlin Romano, Ashka N. Shah, Anett Schumacher et al. · 2023Open reference 2 ↓}

Inverse correlation with depressive symptom severity (PHQ-9 scores, Hamilton depression scores). Restoration of Dialister abundance associated with antidepressant response in both pharmacological and lifestyle interventions.^{[3]Mitchell 2024 — Gastrointestinal, Behaviour and Anxiety Outcomes in Autistic Children Following Synbiotics vs Gut-Directed HypnotherapyLeanne K. Mitchell, Helen S. Heussler, Christopher J. Burgess et al. · 2024Open reference 3 ↓} Depletion predicts treatment-resistant depression.

Mechanistic Links to Neuropsychiatry#

Succinate Production and Mitochondrial Function. Dialister's primary metabolic output is succinate, a key Krebs cycle intermediate and signaling molecule. Succinate deficiency in depression correlates with mitochondrial dysfunction in hippocampal neurons.

Oral succinate supplementation (in rodent models) partially reverses Dialister depletion phenotypes.

Short-Chain Fatty Acid Dysbiosis. Dialister depletion co-occurs with reduced Butyrate and propionate production. Butyrate is essential for histone deacetylase (HDAC) inhibition, which promotes BDNF expression in the brain.

Loss of Dialister contributes to reduced BBB integrity via claudin-5 downregulation.

Lipopolysaccharide (LPS) and Neuroinflammation. Gram-negative Dialister species produce endotoxin, but their presence appears to maintain homeostatic immune tolerance. Dialister depletion allows overgrowth of more aggressive Gram-negative pathogens (e.g., Enterobacteriaceae) with more inflammatory LPS patterns.

The shift in endotoxemia profile (not just total LPS load) drives microglia activation and neuroinflammation.

Vagal Signaling and the Gut-Brain Axis. Dialister metabolites activate GPR43/GPR41 receptors on enteric neurons. Loss of Dialister reduces afferent vagal signaling, impairing top-down parasympathetic control.

Vagal dysfunction is a core feature of treatment-resistant depression and anxiety.

Kynurenine Pathway Dysregulation. Dialister presence (and succinate production) reduces tryptophan shunting into the neurotoxic kynurenine pathway.^{[4]Peng 2023 — Gut Microbiome and Brain Metabolic Remodeling in CP with EpilepsyPeng A, et al. · 2023Open reference 4 ↓} Depletion of Dialister correlates with elevated plasma kynurenine:tryptophan ratios in depression.^{[4]Peng 2023 — Gut Microbiome and Brain Metabolic Remodeling in CP with EpilepsyPeng A, et al. · 2023Open reference 4 ↓}

This shift drives quinolinic acid accumulation in the CNS, contributing to excitotoxicity.

Protective Role in Healthy Periodontium#

Dialister is enriched in healthy gingival tissue and depleted in active periodontitis. Produces weak organic acids (lactate, succinate) that maintain gingival pH and inhibit pathogenic species like Porphyromonas gingivalis. Competes for iron and glycan niches with periodontal pathogens.

Periodontitis-Depression Link#

Patients with severe periodontitis show Dialister depletion in both oral and gut microbiota. The shared depletion pattern suggests a systemic dysbiosis extending from oral to enteric compartments. Periodontal intervention (plaque removal, antimicrobial rinses) partially restores Dialister in responders.

Metal Dependencies#

Iron: Dialister possesses iron-dependent fermentation enzymes and citrate lyase. Iron restriction may impair succinate production efficiency. Prefers iron-limited conditions in the colon; iron overload (common in dysbiosis-associated states) favors pathogenic competitors.

Detection and Quantification#

16S rRNA profiling: Genus-level quantification via high-throughput sequencing. Species-specific qPCR: D. invisus most commonly targeted for functional studies. Metabolomics: Serum and fecal succinate levels as proxy for Dialister activity.

Typical abundance: 0.5–5% of fecal microbiota in healthy individuals; <0.5% in depression.